- Home
- SGMT vs WEA Comparison
SGMT vs WEA Comparison
Compare SGMT & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- WEA
- Stock Information
- Founded
- SGMT 2006
- WEA 2002
- Country
- SGMT United States
- WEA United States
- Employees
- SGMT N/A
- WEA N/A
- Industry
- SGMT
- WEA Trusts Except Educational Religious and Charitable
- Sector
- SGMT
- WEA Finance
- Exchange
- SGMT Nasdaq
- WEA Nasdaq
- Market Cap
- SGMT 159.0M
- WEA 129.3M
- IPO Year
- SGMT 2023
- WEA N/A
- Fundamental
- Price
- SGMT $4.39
- WEA $11.13
- Analyst Decision
- SGMT Buy
- WEA
- Analyst Count
- SGMT 6
- WEA 0
- Target Price
- SGMT $23.00
- WEA N/A
- AVG Volume (30 Days)
- SGMT 1.2M
- WEA 46.1K
- Earning Date
- SGMT 11-13-2024
- WEA 01-01-0001
- Dividend Yield
- SGMT N/A
- WEA 7.87%
- EPS Growth
- SGMT N/A
- WEA N/A
- EPS
- SGMT N/A
- WEA N/A
- Revenue
- SGMT N/A
- WEA N/A
- Revenue This Year
- SGMT N/A
- WEA N/A
- Revenue Next Year
- SGMT N/A
- WEA N/A
- P/E Ratio
- SGMT N/A
- WEA N/A
- Revenue Growth
- SGMT N/A
- WEA N/A
- 52 Week Low
- SGMT $2.39
- WEA $9.60
- 52 Week High
- SGMT $20.71
- WEA $11.29
- Technical
- Relative Strength Index (RSI)
- SGMT 44.30
- WEA 64.33
- Support Level
- SGMT $4.06
- WEA $10.59
- Resistance Level
- SGMT $7.38
- WEA $10.79
- Average True Range (ATR)
- SGMT 0.63
- WEA 0.19
- MACD
- SGMT -0.11
- WEA 0.05
- Stochastic Oscillator
- SGMT 9.94
- WEA 98.18
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.